SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF VETERINARY MEDICAL PRODUCT
Vetzyme One Dose Wormer for Large Dogs
2.
QUALITATIVE & QUANTITATIVE COMPOSITION
Each tablet contains 500mg nitroscanate
3.
PHARMACEUTICAL FORM
Film-coated tablet
4.
PHARMACOLOGICAL PROPERTIES
Broad spectrum anthelmintic
ATC Vet Code: QP52AX01
5.
5.1
CLINICAL PARTICULARS
Target Species
Dogs
5.2
Indications for use
Vetzyme One Dose Wormer is a broad spectrum anthelmintic for use in dogs.
It is highly effective in a single dose against common canine nematodes and
cestodes in the UK. Toxocara canis, Toxacaris leonina, Ancylostoma
caninum, Uncinaria stenocephala, Taenia ovis, Taenia hydatigena, Taenia
pisiformis and Dipylidium caninum.
At the recommended dosage, Lopatol gives only limited control of
Echinococcus granulosus.
5.3
Contra-indications
Tablets are film coated and should not be broken or divided.
5.4
Undesirable effects
The tablets, when administered as recommended are unlikely to cause
vomiting. Do not repeat treatment if vomiting occurs shortly after dosing.
5.5
Special precautions for use
None
5.6
Use during pregnancy and lactation
Not contraindicated in pregnant animals. Nursing bitches should be treated at
same time and as frequently as puppies up to 12 weeks of age, i.e. 2, 4, 6, 8,
12 weeks
5.7
Interaction with other medicaments and other forms of interaction
None known
5.8
Posology and method of administration
For oral administration only.
For the routine treatment of adult dogs and puppies weighing more than 6Kg,
the dose of nitroscanate is 50mg/kg (1 x 500mg tablet per 10kg/22lb
bodyweight).
Practical dosage regime: 500mg tablets
Bodyweight
Number of tablets
6.1 - 10kg
10.1 - 20kg
20.1 - 30kg
30.1 – 40Kg
1 x 500mg
2 x 200mg
3 x 500mg
4 x 500mg
For best results give the tablets together with about one-fifth of the daily food
ration in the morning when the dogs stomach is empty. Give the remaining
food ration in the evening. The tablets should be given whole.
5.9
Overdose
Overdose may cause nausea and vomiting. High doses may have CNS
effects. Treat symptomatically.
5.10
Special warnings for each target species
None.
5.11
Withdrawal periods
Not applicable
5.12
Special precautions to be taken by the person administering the product
None.
6.
6.1
PHARMACEUTICAL PARTICULARS
Incompatibilities (major)
None known
6.2
Shelf-life
5 years
6.3
Special precautions for storage
Do not store above 25°C
Store in a dry place
6.4
Nature and contents of container
Polyethylene-coated aluminium foil strip-pack containing film coated tablets.
Pack sizes 4 tablets.
6.5
Name or style and permanent address or registered place of business of
the holder of the authorisation to place the product on the market
Novartis Animal Health UK Ltd
New Cambridge House
Litlington
Nr. Royston
Herts
SG8 0SS
6.6
Special precautions for the disposal of unused product or waste
materials, if any
None.
7.
FINAL INFORMATION
Marketing authorisation number: Vm 12501/4065
Date of Revision of SPC: 12th January 2006
Date of first authorisation/last renewal: 23rd June 2005